Jaume Mora Graupera
Jefe de Grupo Senior
Research group
Professional network profiles
Last Publications
- Mora J, Modak S, Kinsey J, Ragsdale CE and Lazarus HM GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma INTERNATIONAL JOURNAL OF CANCER . 154(8): 1340-1364.
- Llurba E, Fàtima Crispi Brillas, Crovetto F, Youssef L, Delgado JL, Puig I, Mora J, Krofta L, Mackova K, Martinez-Varea A, Tubau A, Ruiz-Llobet A, Paya A, Prat M, Chantraine F, Comas C, Kajdy A, Lopez-Tinajero MF, Figueras-Retuerta F and Gratacós E Multicentre randomised trial of screening with sFlt1/PlGF and planned delivery to prevent pre-eclampsia at term: protocol of the PE37 study. BMJ Open . 14(3): .
- Villasante A, Corominas J, Alcon C, Garcia-Lizarribar A, Mora J, Lopez-Fanarraga M and Samitier J Identification of GB3 as a Novel Biomarker of Tumor-Derived Vasculature in Neuroblastoma Using a Stiffness-Based Model Cancers . 16(5): .
Projects
- Project name:
- Ayuda Ramon y Cajal. Beneficiari: Sandra Castillo
- Leader
- Jaume Mora Graupera
- Funding entities:
- Ministerio De Ciencia E Innovacion
- Code
- RYC2022-035574-I
- Starting - finishing date:
- 2024 - 2029
- Project name:
- Ensayo clínico de seguridad y factibilidad de inmunoterapia celular: Células dendríticas autólogas pulsadas con un lisado de líneas tumorales alogénicas, asociadas con CART anti-IL13Ra2 en pacientes con tumor difuso intrínseco de tronco (DIPG) (fase Ib)
- Leader
- Andrés Morales La Madrid
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- ICI23/00063
- Starting - finishing date:
- 2024 - 2027
- Project name:
- Plataforma de Biobanco, Biomodelos e Impresión 3D Sant Joan de Déu como paradigma de excelencia en investigacion Pediatrica.
- Leader
- Cristina Jou Muñoz
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PT23/00002
- Starting - finishing date:
- 2024 - 2026
News
-
Researchers from IRSJD and IRB Barcelona unveil the origin of second pediatric cancers and chemotherapy-induced mutations in healthy tissues
A team from Institut de Recerca Sant Joan de Déu and IRB Barcelona has studied the cases of four children who have experienced two cancers during childhood and has addressed the origin of the second tumour. The work has been published in the journal Cancer Discovery.
-
New research facilities for studying children's cancer
New facilities have been opened for the children's oncology laboratory of the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children's Hospital to celebrate 20 years of research. These laboratories are unique in their exclusive dedication to pediatric tumors and have over 50 researchers who focus on the study of more than ten developmental tumors.
-
Researchers at IRSJD develop a method to predict the efficacy of a potent nanomedicine in a severe childhood cancer
Researchers at IRSJD have developed a method that predicts the anticancer efficacy of nab-paclitaxel, a well-known nanomedicine, in mouse models, for treatment of Ewing sarcoma, a severe cancer affecting the bones and soft tissue of children and adolescents.
More activities
-
First International Symposium on Transdisciplinary Approaches for Neuroblastoma Therapy
Auditorium SJD Pediatric Cancer Center Barcelona